Novartis Ag (NVS) Long-Term Investments (2009 - 2026)

Novartis Ag's Long-Term Investments history runs 15 years deep, the most recent figure standing at $100.0 million for Q1 2026.

• In Q1 2026, Long-Term Investments fell 12.28% year-over-year to $100.0 million; the TTM figure through Mar 2026 stood at $100.0 million (down 12.28% YoY), while the FY2025 annual figure was $98.0 million, down 17.65% from the prior year.
• Long-Term Investments came in at $100.0 million for Q1 2026 at Novartis Ag, up from $98.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $2.4 billion in Q2 2022 to a low of $46.0 million in Q1 2023.
• A 5-year average of $615.5 million and a median of $143.0 million in 2022 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments sank 76.41% in 2023 and surged 106.52% in 2024, its largest moves.
• Novartis Ag's Long-Term Investments stood at $143.0 million in 2022, then soared by 43.36% to $205.0 million in 2023, then plunged by 41.95% to $119.0 million in 2024, then fell by 17.65% to $98.0 million in 2025, then advanced by 2.04% to $100.0 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $100.0 million, $98.0 million, and $85.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison